p15(PAF), a novel PCNA associated factor with increased expression in tumor tissues - Wikidata - wikimedia - TriplyDB

p15(PAF), a novel PCNA associated factor with increased expression in tumor tissues

p15(PAF), a novel PCNA associated factor with increased expression in tumor tissues

http://www.wikidata.org/entity/Q28213871

about

sameAs

Proliferating cell nuclear antigen (PCNA)-associated KIAA0101/PAF15 protein is a cell cycle-regulated anaphase-promoting complex/cyclosome substrate KIAA0101 interacts with BRCA1 and regulates centrosome number Structure of p15(PAF)-PCNA complex and implications for clamp sliding during DNA replication and repair Mucosal effects of tenofovir 1% gel PAF and EZH2 induce Wnt/β-catenin signaling hyperactivation.Aerosol delivery of small hairpin osteopontin blocks pulmonary metastasis of breast cancer in mice.Robust multi-tissue gene panel for cancer detection KIAA0101 is overexpressed, and promotes growth and invasion in adrenal cancer.PAF-mediated MAPK signaling hyperactivation via LAMTOR3 induces pancreatic tumorigenesis.p15PAF is an intrinsically disordered protein with nonrandom structural preferences at sites of interaction with other proteins.Computational protein design suggests that human PCNA-partner interactions are not optimized for affinity.Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome p15(PAF) is an Rb/E2F-regulated S-phase protein essential for DNA synthesis and cell cycle progression Multidimensional analysis of gene expression reveals TGFB1I1-induced EMT contributes to malignant progression of astrocytomas.The Paf oncogene is essential for hematopoietic stem cell function and development.A novel role for the mono-ADP-ribosyltransferase PARP14/ARTD8 in promoting homologous recombination and protecting against replication stress Binding cavities and druggability of intrinsically disordered proteins.Deregulation of miR-183 and KIAA0101 in Aggressive and Malignant Pituitary Tumors PAF-Wnt signaling-induced cell plasticity is required for maintenance of breast cancer cell stemness.Analysis of gene expression in a developmental context emphasizes distinct biological leitmotifs in human cancers.KIAA0101 is associated with human renal cell carcinoma proliferation and migration induced by erythropoietin.KIAA0101, a target gene of miR-429, enhances migration and chemoresistance of epithelial ovarian cancer cells.Mass spectrometry (LC-MS/MS) site-mapping of N-glycosylated membrane proteins for breast cancer biomarkers.A network-pathway based module identification for predicting the prognosis of ovarian cancer patients.Paf15 expression correlates with rectal cancer prognosis, cell proliferation and radiation response.ING1 and ING2: multifaceted tumor suppressor genes.Regulation of Rad6/Rad18 Activity During DNA Damage Tolerance.miR-200b induces cell cycle arrest and represses cell growth in esophageal squamous cell carcinoma.Potential Antitumor Activity and Apoptosis Induction of Glossostemon bruguieri Root Extract against Hepatocellular Carcinoma Cells.A functional role for NS5ATP9 in the induction of HCV NS5A-mediated autophagy.Expression of KIAA0101 protein is associated with poor survival of esophageal cancer patients and resistance to cisplatin treatment in vitro.NS5ATP9 contributes to inhibition of cell proliferation by hepatitis C virus (HCV) nonstructural protein 5A (NS5A) via MEK/extracellular signal regulated kinase (ERK) pathway.Elevated KIAA0101 expression is a marker of recurrence in human gastric cancer.Identification of genes differentially expressed in menstrual breakdown and repair.ATF3 and p15PAF are novel gatekeepers of genomic integrity upon UV stress.Variant 2 of KIAA0101, antagonizing its oncogenic variant 1, might be a potential therapeutic strategy in hepatocellular carcinoma.Identification of evolutionarily conserved genetic regulators of cellular aging.NS5ATP9 Promotes Beclin 1-Dependent Starvation-Induced Autophagy of Hepatoblastoma Cells.NS5ATP9 suppresses activation of human hepatic stellate cells, possibly via inhibition of Smad3/phosphorylated-Smad3 expression.Regulation of ubiquitin chain initiation to control the timing of substrate degradation.

P2860

Q24305097-E57E612B-BBA6-45D0-B626-2B1E839CBC53 Q24306544-0FE29CDB-3DC2-4552-B07C-B1A6C261513D Q27698433-9B260C4D-0F2C-44F3-8056-A65430A089B9 Q28545969-EC9BC322-1F25-4CCB-B18F-37ABDF770FB1 Q33693019-8D889194-4366-4A83-8094-0CF57034CE0C Q33784690-0B548537-7F76-4CE6-B60D-58B32221839B Q34004624-C4A853FB-B24F-4B6F-BDEA-A3036EDE6B30 Q34077707-A2D35CEE-E176-4FC1-B713-B3582589B2E4 Q34147719-BA09A8FA-D931-4228-941E-501F044AB496 Q34406035-B8ACF03E-7F56-43DE-994C-03F18FEDFC8D Q34421580-12FB2561-EB09-493B-B088-03A874136C8A Q34530428-EE9645F3-0116-4425-84EF-8B440605EEC0 Q34674763-6A14063E-F71F-4452-8C1F-2BB3786ECCF9 Q35149628-D4E3A782-161D-4B72-A9C6-4E3D2D29F722 Q35208362-EF824113-07D7-4F1A-8F47-A422E0D6B200 Q35237048-A90F7B52-072F-4C3D-8880-9C1EAF4B2E7E Q35571730-FBA21168-276B-4BEA-B9A7-2FF270E5EFA0 Q35932525-F19E7816-5D43-40AA-AB01-68539E50951A Q36549367-06F21462-A812-41C1-9C0F-D50BC915B07A Q36864745-7166CE7E-4CC5-4ACE-8226-261028D4C4CC Q37046380-4D78DD6C-5CEE-442B-91E4-85E697A1E01F Q37286094-F5F0E319-D6F9-4F2E-BA43-DEB1938DCE59 Q37385278-4C6FA8F8-533E-43CA-8A9B-C1618D476701 Q37390796-D920B543-48CA-4DE1-83DA-D5088B66B26C Q37437654-ACB25A9D-746F-4B2A-8528-AE0B9D375454 Q38081784-64019AFF-7F43-4293-9D63-5D5B0FB1B534 Q38534219-6CE0D329-25A9-443D-8770-2E4F20A6EBD5 Q38753529-FB7BF21C-D37E-4BC1-B14C-5C131B866864 Q38831293-CDEE5C13-60F1-4A9E-80EC-2E4B07615B0A Q39002495-A2E2860E-AAB5-42F4-9FA9-BBE1D13A1669 Q39075118-886B24C5-1E46-4954-9E41-58B10B9F6011 Q39148519-CFC2FB03-629A-4706-A1DB-A5AE2BBA44E6 Q39226030-73B66FE6-DBD2-46EC-9A4D-4F7A534F9AD6 Q39408500-BC1E9692-C897-4B09-8DA4-DAA797639D00 Q39883585-FE8319DF-3932-48F8-A15B-B13A10D8F3D7 Q40250784-9A87A137-9933-4DDD-BEE0-6E2F946845C8 Q41207120-588A043C-4C71-4EF6-9A2C-D5AB54BF1C41 Q41504921-4D1FFD8F-B658-46DC-B6A1-7B703EA37B25 Q41707896-49C4C3D3-99F9-47F7-B797-0898226CAB88 Q42778545-628F99D4-536D-4ABB-B03A-8A8FD6659A48

P2860

p15(PAF), a novel PCNA associated factor with increased expression in tumor tissues

http://www.wikidata.org/entity/Q28213871

description

2001 nî lūn-bûn

@nan

2001 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

p15(PAF), a novel PCNA associated factor with increased expression in tumor tissues

@ast

p15(PAF), a novel PCNA associated factor with increased expression in tumor tissues

@en

p15(PAF), a novel PCNA associated factor with increased expression in tumor tissues

@nl

type

label

p15(PAF), a novel PCNA associated factor with increased expression in tumor tissues

@ast

p15(PAF), a novel PCNA associated factor with increased expression in tumor tissues

@en

p15(PAF), a novel PCNA associated factor with increased expression in tumor tissues

@nl

prefLabel

p15(PAF), a novel PCNA associated factor with increased expression in tumor tissues

@ast

p15(PAF), a novel PCNA associated factor with increased expression in tumor tissues

@en

p15(PAF), a novel PCNA associated factor with increased expression in tumor tissues

@nl

P1433

Q28213871-A7E6C57E-1F0F-4EDA-8679-EC1E5AE2EF46

P1476

Q28213871-422B32B6-3BDE-439D-B141-6EBF64337FEB

P2093

Q28213871-0A245D98-5176-4922-A024-6E4A7DA3E694

Q28213871-0EEC6349-9489-4C29-83B5-71F89107A436

Q28213871-3A463B3E-12E2-406E-9199-07DCD36D5E97

Q28213871-65660CCB-54C7-4AB5-9156-644B68C3732D

Q28213871-9A32A9AF-F8A5-45F0-B6FD-A5D3EC6C9B09

Q28213871-AC0C10BC-F567-49CE-A1F4-82517415F493

Q28213871-BF0672B1-18DD-4E7C-8435-D078391A0E5D

Q28213871-D632CC04-C559-4A07-84CD-EE111DB9DB03

Q28213871-F611792A-4D6B-47A2-8742-8AD2BDE294BB

P2860

Q28213871-2A988C84-2586-45F4-93DD-698D388BC01C

Q28213871-2C748B2D-DC54-4A6E-98D4-545D0F5AF0B6

Q28213871-2D813EB6-64AC-4E7E-9434-85103B30D9C2

Q28213871-323A7AA4-FCB7-4D70-9B6E-74B50DBF1514

Q28213871-3A0922B6-1BD8-4211-958A-9C825CF43E27

Q28213871-53FC2FF9-7651-44E5-A3DC-7115C807786D

Q28213871-567A63FF-6A0B-43D9-B5BF-0399FB56B921

Q28213871-66F2944B-C539-41D7-BE7E-88929930BAA3

Q28213871-6CB7FDD4-83FA-4556-95AE-07725A3B5A92

Q28213871-6D8C51F3-C458-4878-B5DB-509B8749D825

P2888

Q28213871-43C7F201-CF44-461E-8B5D-F993A28C7F9E

P304

Q28213871-652FEBA7-49AC-481C-A79A-8EDBE4226509

P31

Q28213871-162E51CA-C73F-4DCE-A757-4D52C493FE6D

P3181

Q28213871-85DC11E9-D978-4AE6-ADF4-9A44A36BA5BC

P356

Q28213871-7F78D33E-EBA0-4F61-AC55-A48EE37DFA2C

P407

Q28213871-2D77A9DC-937C-479D-8532-1C6F428CFD6B

P433

Q28213871-CCDE1B71-A09C-48D8-A0D4-E53BDF6E3409

P478

Q28213871-81B966A1-201D-42FA-A7CD-2D91FE027999

P577

Q28213871-84CE90E1-A5BC-4D5C-A091-F90D26501867

P5875

Q28213871-F0A209BD-1E9E-4420-92B3-9DCE89CDA7D9

P6179

Q28213871-264571D0-5370-4A1D-A5B7-A9C73B25C63F

P698

Q28213871-BB342F27-8337-48A0-9D0D-DAE9B7482056

P3181

P356

P1433

P1476

p15(PAF), a novel PCNA associated factor with increased expression in tumor tissues

@en

P2093

B Huang

http://www.w3.org/2001/XMLSchema#string

C Lau

http://www.w3.org/2001/XMLSchema#string

D G Payan

http://www.w3.org/2001/XMLSchema#string

E Chan

http://www.w3.org/2001/XMLSchema#string

J Michel

http://www.w3.org/2001/XMLSchema#string

M Shen

http://www.w3.org/2001/XMLSchema#string

P Yu

http://www.w3.org/2001/XMLSchema#string

Y Luo

http://www.w3.org/2001/XMLSchema#string

Y Xiong

http://www.w3.org/2001/XMLSchema#string

P2860

Human DNA-(Cytosine-5) Methyltransferase-PCNA Complex as a Target for p21WAF1

Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen

The DNA repair endonuclease XPG binds to proliferating cell nuclear antigen (PCNA) and shares sequence elements with the PCNA-binding regions of FEN-1 and cyclin-dependent kinase inhibitor p21

Identification of DNA replication and cell cycle proteins that interact with PCNA

Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen

Structure of the C-terminal region of p21(WAF1/CIP1) complexed with human PCNA

A novel genetic system to detect protein-protein interactions

Lagging strand DNA synthesis at the eukaryotic replication fork involves binding and stimulation of FEN-1 by proliferating cell nuclear antigen

Requirement for PCNA in DNA mismatch repair at a step preceding DNA resynthesis.

D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA

P2888

P304

484-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3338509

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/SJ.ONC.1204113

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2001-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12020791

http://www.w3.org/2001/XMLSchema#string

P6179

1029799433

http://www.w3.org/2001/XMLSchema#string

P698

11313979

http://www.w3.org/2001/XMLSchema#string